These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6354780)

  • 1. Immunoreactivity of human insulin of recombinant DNA origin.
    Kumar D; Alexander CM; Zeidler A; Rhodes JJ; Boarman CC; Hoopes MT
    Diabetes; 1983 Jun; 32(6):516-9. PubMed ID: 6354780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity of IgG-insulin antibodies to human (recombinant DNA) insulin and porcine insulin in insulin-treated diabetic individuals with and without insulin resistance.
    Schernthaner G
    Diabetes Care; 1982; 5 Suppl 2():114-8. PubMed ID: 6765520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of immunoglobulin E and immunoglobulin G against human (recombinant DNA) insulin in human insulin allergy and resistance.
    Grammer LC; Roberts M; Buchanan TA; Fitzsimons R; Metzger BE; Patterson R
    J Lab Clin Med; 1987 Feb; 109(2):141-6. PubMed ID: 3543177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects.
    Fireman P; Fineberg SE; Galloway JA
    Diabetes Care; 1982; 5 Suppl 2():119-25. PubMed ID: 6765521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific IgE antibody response to human insulin in diabetic subjects.
    Marcos C; Cuesta J; Cuevas M; Balsa J; Fraj J; Alvarez-Cuesta E
    Allergol Immunopathol (Madr); 1993; 21(4):141-4. PubMed ID: 8237718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgE and IgG antibody against human (recombinant DNA) insulin in patients with systemic insulin allergy.
    Grammer LC; Roberts M; Patterson R
    J Lab Clin Med; 1985 Jan; 105(1):108-13. PubMed ID: 3881543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-specific IgG and IgE antibody response in type I diabetic subjects exclusively treated with human insulin (recombinant DNA).
    Velcovsky HG; Federlin KF
    Diabetes Care; 1982; 5 Suppl 2():126-8. PubMed ID: 6765522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of recombinant DNA human insulin.
    Fineberg SE; Galloway JA; Fineberg NS; Rathbun MJ; Hufferd S
    Diabetologia; 1983 Dec; 25(6):465-9. PubMed ID: 6198228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin antibodies: reduction in various anti-insulin IgG subclasses with human insulin therapy.
    Kumar D
    Horm Metab Res; 1993 Jul; 25(7):360-4. PubMed ID: 8406321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-insulin IgE in diabetics.
    Kumar D
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1159-64. PubMed ID: 591613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human anti-insulin IgG autoantibody apparently arises through clonal selection from an insulin-specific "germ-line" natural antibody template. Analysis by V gene segment reassortment and site-directed mutagenesis.
    Ichiyoshi Y; Zhou M; Casali P
    J Immunol; 1995 Jan; 154(1):226-38. PubMed ID: 7995943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of insulin specific IgE in serum of diabetic patients by solid-phase radioimmunoassay.
    Falholt K
    Diabetologia; 1982 Apr; 22(4):254-7. PubMed ID: 7047272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a rapid enzyme-linked immunosorbent microassay (ELISA) to study human anti-insulin antibody.
    Nell LJ; Virta VJ; Thomas JW
    Diabetes; 1985 Jan; 34(1):60-6. PubMed ID: 3880549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy of human and porcine insulin in treatment of diabetic ketoacidosis.
    Storms FE; Lutterman JA; van't Laar A
    Diabetes Care; 1987; 10(1):49-55. PubMed ID: 3105986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of biosynthetic human LysPro insulin compared to native-sequence human and purified porcine insulins in rhesus monkeys immunized over a 6-week period.
    Zwickl CM; Smith HW; Zimmermann JL; Wierda D
    Arzneimittelforschung; 1995 Apr; 45(4):524-8. PubMed ID: 7779155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of IgG subclasses on in vivo bioavailability and metabolic fate of immune-complexed insulin in Lewis rats.
    Arquilla ER; Stenger D; McDougall B; Ulich TR
    Diabetes; 1987 Oct; 36(10):1144-51. PubMed ID: 3308585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lispro analog for treatment of generalized allergy to human insulin.
    Kumar D
    Diabetes Care; 1997 Sep; 20(9):1357-9. PubMed ID: 9283778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence and clinical meaning of insulin-specific IgE antibodies].
    Tosoni C; Cattaneo R; Valentini U; Rocca L; Marchetti C; Braga M
    Medicina (Firenze); 1990; 10(4):396-8. PubMed ID: 2099982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and targeting of T-cell immune responses by IgE and IgG antibodies.
    Bheekha Escura R; Wasserbauer E; Hammerschmid F; Pearce A; Kidd P; Mudde GC
    Immunology; 1995 Nov; 86(3):343-50. PubMed ID: 8550069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The blocking activity of birch pollen-specific immunotherapy-induced IgG4 is not qualitatively superior to that of other IgG subclasses.
    Ejrnaes AM; Bodtger U; Larsen JN; Svenson M
    Mol Immunol; 2004 Jul; 41(5):471-8. PubMed ID: 15183926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.